Tumor-derived Parathyroid Hormone-Related Protein Is Associated with Suppression of Cytochrome P450 Expression:

Issei Fujita1, Tsubasa Kaji2, Isamu Noguchi2

  • 1Department of Clinical Pharmacy and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan.

Insights

Tumor-derived parathyroid hormone-related protein (PTHrP) is linked to suppressed drug metabolism in cancer cachexia by downregulating cytochrome P450 (CYP) enzymes. This suggests PTHrP may be a biomarker for altered drug pharmacokinetics.

Area of Science:

  • Pharmacology
  • Oncology
  • Biochemistry

Background:

  • Cancer cachexia often involves altered drug metabolism and increased chemotherapy toxicity.
  • Downregulation of cytochrome P450 (CYP) enzymes contributes to these metabolic changes.
  • The precise molecular mechanisms behind this broad metabolic suppression are not fully understood.

Purpose of the Study:

  • To investigate the association between tumor-derived parathyroid hormone-related protein (PTHrP) and the suppression of multiple CYP enzyme families.
  • To determine if PTHrP contributes to the downregulation of drug-metabolizing enzymes in cancer cachexia.

Main Methods:

  • Utilized a rat cachexia model to assess CYP expression and pharmacokinetics.
  • Conducted in vitro experiments with primary rat hepatocytes and PTHrP treatment.
  • Analyzed human The Cancer Genome Atlas (TCGA) hepatocellular carcinoma (HCC) data.
  • Employed single-cell RNA sequencing and spatial transcriptomics for detailed analysis.

Main Results:

  • Significant downregulation of CYP3A, CYP1A, CYP2C, CYP2D, and CYP2E1 in liver and small intestine of cachectic rats.
  • Increased drug AUC and reduced clearance observed in pharmacokinetic analyses.
  • PTHrP treatment reduced CYP isoform expression in primary rat hepatocytes.
  • Negative correlation between PTHrP and CYP gene expression in human HCC data, linked to NF-κB pathways.
  • PTHrP-high tumor regions showed suppressed xenobiotic metabolism.
  • High tumor PTHrP correlated with reduced CYP expression in adjacent nontumor hepatocytes in liver metastases.

Conclusions:

  • Tumor-derived PTHrP is associated with the suppression of drug-metabolizing CYP enzymes in cancer cachexia.
  • PTHrP is a potential contributing factor to the metabolic suppression observed in cancer patients.
  • PTHrP warrants further investigation as a candidate biomarker for altered drug metabolism and toxicity, requiring mechanistic and clinical validation.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...